cbdMD (YCBD) Share-based Compensation Growth (1y) (2018 - 2025)
cbdMD (YCBD) Share-based Compensation Growth (1y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 26.47% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 47.06% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 8.79% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 281.05% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 92.83% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 5.49% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 61.54% |
| 10 | cbdMD | 438,678.80 | -2.95 Mn | 3.00 Mn | -96.95% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -96.95% |
| Sep 30, 2025 | 4,146.34% |
| Sep 30, 2024 | 136.78% |
| Sep 30, 2023 | -106.71% |
| Jun 30, 2023 | -97.91% |
| Mar 31, 2023 | -83.94% |
| Dec 31, 2022 | -91.46% |
| Sep 30, 2022 | 92.84% |
| Jun 30, 2022 | -33.81% |
| Mar 31, 2022 | -38.20% |
| Dec 31, 2021 | 3,229.76% |
| Sep 30, 2021 | -115.65% |
| Mar 31, 2021 | 23.73% |
| Dec 31, 2020 | -97.18% |
| Sep 30, 2020 | 91.65% |
| Mar 31, 2020 | 445.49% |
| Dec 31, 2019 | 277.65% |
| Sep 30, 2019 | 417.39% |
| Jun 30, 2019 | 506.03% |
| Mar 31, 2019 | -721.80% |